Evolution of haematopoietic cell transplantation for canine blood disorders and a platform for solid organ transplantation

Abstract Pre‐clinical haematopoietic cell transplantation (HCT) studies in canines have proven to be invaluable for establishing HCT as a highly successful clinical option for the treatment of malignant and non‐malignant haematological diseases in humans. Additionally, studies in canines have shown...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Scott S. Graves, Rainer Storb
Formato: article
Lenguaje:EN
Publicado: Wiley 2021
Materias:
Acceso en línea:https://doaj.org/article/d270e6c7822e4b129576c86994021aca
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:d270e6c7822e4b129576c86994021aca
record_format dspace
spelling oai:doaj.org-article:d270e6c7822e4b129576c86994021aca2021-11-19T17:14:25ZEvolution of haematopoietic cell transplantation for canine blood disorders and a platform for solid organ transplantation2053-109510.1002/vms3.601https://doaj.org/article/d270e6c7822e4b129576c86994021aca2021-11-01T00:00:00Zhttps://doi.org/10.1002/vms3.601https://doaj.org/toc/2053-1095Abstract Pre‐clinical haematopoietic cell transplantation (HCT) studies in canines have proven to be invaluable for establishing HCT as a highly successful clinical option for the treatment of malignant and non‐malignant haematological diseases in humans. Additionally, studies in canines have shown that immune tolerance, established following HCT, enabled transplantation of solid organs without the need of lifelong immunosuppression. This progress has been possible due to multiple biological similarities between dog and mankind. In this review, the hurdles that were overcome and the methods that were developed in the dog HCT model which made HCT clinically possible are examined. The results of these studies justify the question whether HCT can be used in the veterinary clinical practice for more wide‐spread successful treatment of canine haematologic and non‐haematologic disorders and whether it is prudent to do so.Scott S. GravesRainer StorbWileyarticlecaninekidneylymphomastem celltransplantationVeterinary medicineSF600-1100ENVeterinary Medicine and Science, Vol 7, Iss 6, Pp 2156-2171 (2021)
institution DOAJ
collection DOAJ
language EN
topic canine
kidney
lymphoma
stem cell
transplantation
Veterinary medicine
SF600-1100
spellingShingle canine
kidney
lymphoma
stem cell
transplantation
Veterinary medicine
SF600-1100
Scott S. Graves
Rainer Storb
Evolution of haematopoietic cell transplantation for canine blood disorders and a platform for solid organ transplantation
description Abstract Pre‐clinical haematopoietic cell transplantation (HCT) studies in canines have proven to be invaluable for establishing HCT as a highly successful clinical option for the treatment of malignant and non‐malignant haematological diseases in humans. Additionally, studies in canines have shown that immune tolerance, established following HCT, enabled transplantation of solid organs without the need of lifelong immunosuppression. This progress has been possible due to multiple biological similarities between dog and mankind. In this review, the hurdles that were overcome and the methods that were developed in the dog HCT model which made HCT clinically possible are examined. The results of these studies justify the question whether HCT can be used in the veterinary clinical practice for more wide‐spread successful treatment of canine haematologic and non‐haematologic disorders and whether it is prudent to do so.
format article
author Scott S. Graves
Rainer Storb
author_facet Scott S. Graves
Rainer Storb
author_sort Scott S. Graves
title Evolution of haematopoietic cell transplantation for canine blood disorders and a platform for solid organ transplantation
title_short Evolution of haematopoietic cell transplantation for canine blood disorders and a platform for solid organ transplantation
title_full Evolution of haematopoietic cell transplantation for canine blood disorders and a platform for solid organ transplantation
title_fullStr Evolution of haematopoietic cell transplantation for canine blood disorders and a platform for solid organ transplantation
title_full_unstemmed Evolution of haematopoietic cell transplantation for canine blood disorders and a platform for solid organ transplantation
title_sort evolution of haematopoietic cell transplantation for canine blood disorders and a platform for solid organ transplantation
publisher Wiley
publishDate 2021
url https://doaj.org/article/d270e6c7822e4b129576c86994021aca
work_keys_str_mv AT scottsgraves evolutionofhaematopoieticcelltransplantationforcanineblooddisordersandaplatformforsolidorgantransplantation
AT rainerstorb evolutionofhaematopoieticcelltransplantationforcanineblooddisordersandaplatformforsolidorgantransplantation
_version_ 1718420039504232448